TY - JOUR AU - Alinaghi, F. a. r. z. a. d. AU - Calov, M. o. n. i. k. a. AU - Kristensen, L. a. r. s. E. r. i. k. AU - Gladman, D. a. f. n. a. D. AU - Coates, L. a. u. r. a. C. AU - Jullien, D. e. n. i. s. AU - Gottlieb, A. l. i. c. e. B. AU - Gisondi, P. a. o. l. o. AU - Wu, J. a. s. h. i. n. J. AU - Thyssen, J. a. c. o. b. P. AU - Egeberg, A. l. e. x. a. n. d. e. r. PY - 2019 DA - 2019// TI - Prevalence of psoriatic arthritis in patients with psoriasis: A systematic review and meta-analysis of observational and clinical studies JO - Journal of the American Academy of Dermatology VL - 80 UR - https://doi.org/10.1016/j.jaad.2018.06.027 DO - 10.1016/j.jaad.2018.06.027 ID - Alinaghi2019 ER - TY - JOUR AU - Coates, L. C. AU - Helliwell, P. S. PY - 2017 DA - 2017// TI - Psoriatic arthritis: state of the art review JO - Clin Med. VL - 17 UR - https://doi.org/10.7861/clinmedicine.17-1-65 DO - 10.7861/clinmedicine.17-1-65 ID - Coates2017 ER - TY - JOUR AU - Wassenberg, S. PY - 2015 DA - 2015// TI - Radiographic scoring methods in psoriatic arthritis JO - Clin Exp Rheumatol. VL - 33 ID - Wassenberg2015 ER - TY - STD TI - van der Heijde D, Sharp J, Wassenberg S, Gladman DD. Psoriatic arthritis imaging: a review of scoring methods. Ann Rheum Dis. 2005;64 Suppl 2:ii61–64. ID - ref4 ER - TY - JOUR AU - Kavanaugh, A. AU - Helliwell, P. AU - Ritchlin, C. T. PY - 2016 DA - 2016// TI - Psoriatic arthritis and burden of disease: patient perspectives from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis (MAPP) survey JO - Rheumatol Ther. VL - 3 UR - https://doi.org/10.1007/s40744-016-0029-z DO - 10.1007/s40744-016-0029-z ID - Kavanaugh2016 ER - TY - JOUR AU - Kerschbaumer, A. AU - Baker, D. AU - Smolen, J. S. AU - Aletaha, D. PY - 2017 DA - 2017// TI - The effects of structural damage on functional disability in psoriatic arthritis JO - Ann Rheum Dis. VL - 76 UR - https://doi.org/10.1136/annrheumdis-2017-211433 DO - 10.1136/annrheumdis-2017-211433 ID - Kerschbaumer2017 ER - TY - JOUR AU - Kane, D. AU - Stafford, L. AU - Bresnihan, B. AU - FitzGerald, O. PY - 2003 DA - 2003// TI - A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience JO - Rheumatology. VL - 42 UR - https://doi.org/10.1093/rheumatology/keg384 DO - 10.1093/rheumatology/keg384 ID - Kane2003 ER - TY - JOUR AU - Haroon, M. AU - Gallagher, P. AU - Fitzgerald, O. PY - 2015 DA - 2015// TI - Diagnostic delay of more than 6 months contributes to poor radiographic and functional outcome in psoriatic arthritis JO - Ann Rheum Dis. VL - 74 UR - https://doi.org/10.1136/annrheumdis-2013-204858 DO - 10.1136/annrheumdis-2013-204858 ID - Haroon2015 ER - TY - JOUR AU - Gladman, D. D. AU - Farewell, V. T. AU - Wong, K. AU - Husted, J. PY - 1998 DA - 1998// TI - Mortality studies in psoriatic arthritis: results from a single outpatient center. II. Prognostic indicators for death JO - Arthritis Rheum. VL - 41 UR - https://doi.org/3.0.CO;2-N DO - 3.0.CO;2-N ID - Gladman1998 ER - TY - JOUR AU - Coates, L. C. AU - Kavanaugh, A. AU - Mease, P. J. AU - Soriano, E. R. AU - Laura Acosta-Felquer, M. AU - Armstrong, A. W. PY - 2016 DA - 2016// TI - Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 treatment recommendations for psoriatic arthritis JO - Arthritis Rheumatol. VL - 68 ID - Coates2016 ER - TY - JOUR AU - Gossec, L. AU - Smolen, J. S. AU - Ramiro, S. AU - Wit, M. AU - Cutolo, M. AU - Dougados, M. PY - 2016 DA - 2016// TI - European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update JO - Ann Rheum Dis. VL - 75 UR - https://doi.org/10.1136/annrheumdis-2015-208337 DO - 10.1136/annrheumdis-2015-208337 ID - Gossec2016 ER - TY - JOUR AU - Gladman, D. D. AU - Chandran, V. PY - 2011 DA - 2011// TI - Standardizing the monitoring of outcome measures: imaging in psoriatic arthritis JO - Int J Clin Rheumatol. VL - 6 UR - https://doi.org/10.2217/ijr.10.103 DO - 10.2217/ijr.10.103 ID - Gladman2011 ER - TY - JOUR AU - Rahman, P. AU - Gladman, D. D. AU - Cook, R. J. AU - Zhou, Y. AU - Young, G. AU - Salonen, D. PY - 1998 DA - 1998// TI - Radiological assessment in psoriatic arthritis JO - Br J Rheumatol. VL - 37 UR - https://doi.org/10.1093/rheumatology/37.7.760 DO - 10.1093/rheumatology/37.7.760 ID - Rahman1998 ER - TY - JOUR AU - Wassenberg, S. AU - Fischer-Kahle, V. AU - Herborn, G. AU - Rau, R. PY - 2001 DA - 2001// TI - A method to score radiographic change in psoriatic arthritis JO - Z Rheumatol VL - 60 UR - https://doi.org/10.1007/s003930170064 DO - 10.1007/s003930170064 ID - Wassenberg2001 ER - TY - JOUR AU - Mease, P. J. AU - Kivitz, A. J. AU - Burch, F. X. AU - Siegel, E. L. AU - Cohen, S. B. AU - Ory, P. PY - 2004 DA - 2004// TI - Etanercept treatment of psoriatic arthritis: safety, efficacy, and effect on disease progression JO - Arthritis Rheum. VL - 50 UR - https://doi.org/10.1002/art.20335 DO - 10.1002/art.20335 ID - Mease2004 ER - TY - JOUR AU - Mease, P. J. AU - Kivitz, A. J. AU - Burch, F. X. AU - Siegel, E. L. AU - Cohen, S. B. AU - Ory, P. PY - 2006 DA - 2006// TI - Continued inhibition of radiographic progression in patients with psoriatic arthritis following 2 years of treatment with etanercept JO - J Rheumatol. VL - 33 ID - Mease2006 ER - TY - JOUR AU - Mease, P. J. AU - Gladman, D. D. AU - Ritchlin, C. T. AU - Ruderman, E. M. AU - Steinfeld, S. D. AU - Choy, E. H. PY - 2005 DA - 2005// TI - Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: results of a double-blind, randomized, placebo-controlled trial JO - Arthritis Rheum. VL - 52 UR - https://doi.org/10.1002/art.21306 DO - 10.1002/art.21306 ID - Mease2005 ER - TY - JOUR AU - Mease, P. J. AU - Ory, P. AU - Sharp, J. T. AU - Ritchlin, C. T. AU - Bosch, F. AU - Wellborne, F. PY - 2009 DA - 2009// TI - Adalimumab for long-term treatment of psoriatic arthritis: 2-year data from the Adalimumab Effectiveness in Psoriatic Arthritis Trial (ADEPT) JO - Ann Rheum Dis. VL - 68 UR - https://doi.org/10.1136/ard.2008.092767 DO - 10.1136/ard.2008.092767 ID - Mease2009 ER - TY - JOUR AU - Kavanaugh, A. AU - Antoni, C. E. AU - Gladman, D. AU - Wassenberg, S. AU - Zhou, B. AU - Beutler, A. PY - 2006 DA - 2006// TI - The Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT): results of radiographic analyses after 1 year JO - Ann Rheum Dis. VL - 65 UR - https://doi.org/10.1136/ard.2005.045658 DO - 10.1136/ard.2005.045658 ID - Kavanaugh2006 ER - TY - JOUR AU - Heijde, D. AU - Kavanaugh, A. AU - Gladman, D. D. AU - Antoni, C. AU - Krueger, G. G. AU - Guzzo, C. PY - 2007 DA - 2007// TI - Infliximab inhibits progression of radiographic damage in patients with active psoriatic arthritis through one year of treatment: results from the induction and maintenance psoriatic arthritis clinical trial 2 JO - Arthritis Rheum. VL - 56 UR - https://doi.org/10.1002/art.22805 DO - 10.1002/art.22805 ID - Heijde2007 ER - TY - JOUR AU - Kavanaugh, A. AU - Heijde, D. AU - McInnes, I. B. AU - Mease, P. AU - Krueger, G. G. AU - Gladman, D. D. PY - 2012 DA - 2012// TI - Golimumab in psoriatic arthritis: one-year clinical efficacy, radiographic, and safety results from a phase III, randomized, placebo-controlled trial JO - Arthritis Rheum. VL - 64 UR - https://doi.org/10.1002/art.34436 DO - 10.1002/art.34436 ID - Kavanaugh2012 ER - TY - JOUR AU - Kavanaugh, A. AU - Husni, M. E. AU - Harrison, D. D. AU - Kim, L. AU - Lo, K. H. AU - Leu, J. H. AU - Hsia, E. C. PY - 2017 DA - 2017// TI - Safety and efficacy of intravenous golimumab in patients with active psoriatic arthritis: results through week twenty-four of the GO-VIBRANT study JO - Arthritis Rheumatol. VL - 69 UR - https://doi.org/10.1002/art.40226 DO - 10.1002/art.40226 ID - Kavanaugh2017 ER - TY - JOUR AU - Heijde, D. AU - Fleischmann, R. AU - Wollenhaupt, J. AU - Deodhar, A. AU - Kielar, D. AU - Woltering, F. PY - 2014 DA - 2014// TI - Effect of different imputation approaches on the evaluation of radiographic progression in patients with psoriatic arthritis: results of the RAPID-PsA 24-week phase III double-blind randomised placebo-controlled study of certolizumab pegol JO - Ann Rheum Dis. VL - 73 UR - https://doi.org/10.1136/annrheumdis-2013-203697 DO - 10.1136/annrheumdis-2013-203697 ID - Heijde2014 ER - TY - JOUR AU - Mease, P. J. AU - Fleischmann, R. AU - Deodhar, A. A. AU - Wollenhaupt, J. AU - Khraishi, M. AU - Kielar, D. PY - 2014 DA - 2014// TI - Effect of certolizumab pegol on signs and symptoms in patients with psoriatic arthritis: 24-week results of a phase 3 double-blind randomised placebo-controlled study (RAPID-PsA) JO - Ann Rheum Dis. VL - 73 UR - https://doi.org/10.1136/annrheumdis-2013-203696 DO - 10.1136/annrheumdis-2013-203696 ID - Mease2014 ER - TY - JOUR AU - Kavanaugh, A. AU - Ritchlin, C. AU - Rahman, P. AU - Puig, L. AU - Gottlieb, A. B. AU - Li, S. PY - 2014 DA - 2014// TI - Ustekinumab, an anti-IL-12/23 p40 monoclonal antibody, inhibits radiographic progression in patients with active psoriatic arthritis: results of an integrated analysis of radiographic data from the phase 3, multicentre, randomised, double-blind, placebo-controlled PSUMMIT-1 and PSUMMIT-2 trials JO - Ann Rheum Dis. VL - 73 UR - https://doi.org/10.1136/annrheumdis-2013-204741 DO - 10.1136/annrheumdis-2013-204741 ID - Kavanaugh2014 ER - TY - JOUR AU - Heijde, D. AU - Landewe, R. B. AU - Mease, P. J. AU - McInnes, I. B. AU - Conaghan, P. G. AU - Pricop, L. PY - 2016 DA - 2016// TI - Brief report: secukinumab provides significant and sustained inhibition of joint structural damage in a phase III study of active psoriatic arthritis JO - Arthritis Rheumatol. VL - 68 UR - https://doi.org/10.1002/art.39685 DO - 10.1002/art.39685 ID - Heijde2016 ER - TY - JOUR AU - Mease, P. AU - Heijde, D. AU - Landewé, R. AU - Mpofu, S. AU - Rahman, P. AU - Tahir, H. PY - 2018 DA - 2018// TI - Secukinumab improves active psoriatic arthritis symptoms and inhibits radiographic progression: primary results from the randomised, double-blind, phase III FUTURE 5 study JO - Ann Rheum Dis. VL - 77 ID - Mease2018 ER - TY - JOUR AU - Heijde, D. AU - Gladman, D. D. AU - Kishimoto, M. AU - Okada, M. AU - Rathmann, S. S. AU - Moriarty, S. R. PY - 2018 DA - 2018// TI - Efficacy and safety of ixekizumab in patients with active psoriatic arthritis: 52-week results from a phase III study (SPIRIT-P1) JO - J Rheumatol. VL - 45 UR - https://doi.org/10.3899/jrheum.170429 DO - 10.3899/jrheum.170429 ID - Heijde2018 ER - TY - JOUR AU - Mease, P. J. AU - Gottlieb, A. B. AU - Heijde, D. AU - Fitzgerald, O. AU - Johnsen, A. AU - Nys, M. PY - 2017 DA - 2017// TI - Efficacy and safety of abatacept, a T-cell modulator, in a randomised, double-blind, placebo-controlled, phase III study in psoriatic arthritis JO - Ann Rheum Dis. VL - 76 UR - https://doi.org/10.1136/annrheumdis-2016-210724 DO - 10.1136/annrheumdis-2016-210724 ID - Mease2017 ER - TY - JOUR AU - Mease, P. AU - Hall, S. AU - Fitzgerald, O. AU - Heijde, D. AU - Merola, J. F. AU - Avila-Zapata, F. PY - 2017 DA - 2017// TI - Tofacitinib or adalimumab versus placebo for psoriatic arthritis JO - N Engl J Med. VL - 377 UR - https://doi.org/10.1056/NEJMoa1615975 DO - 10.1056/NEJMoa1615975 ID - Mease2017 ER - TY - JOUR AU - Mease, P. J. AU - Gladman, D. D. AU - Collier, D. H. AU - Ritchlin, C. T. AU - Helliwell, P. S. AU - Liu, L. PY - 2019 DA - 2019// TI - Etanercept and methotrexate as monotherapy or in combination for psoriatic arthritis: primary results from a randomized, controlled phase III trial JO - Arthritis Rheumatol. VL - 71 UR - https://doi.org/10.1002/art.40851 DO - 10.1002/art.40851 ID - Mease2019 ER - TY - JOUR AU - Mease, P. J. AU - Heijde, D. AU - Ritchlin, C. T. AU - Okada, M. AU - Cuchacovich, R. S. AU - Shuler, C. L. PY - 2017 DA - 2017// TI - Ixekizumab, an interleukin-17A specific monoclonal antibody, for the treatment of biologic-naive patients with active psoriatic arthritis: results from the 24-week randomised, double-blind, placebo-controlled and active (adalimumab)-controlled period of the phase III trial SPIRIT-P1 JO - Ann Rheum Dis. VL - 76 UR - https://doi.org/10.1136/annrheumdis-2016-209709 DO - 10.1136/annrheumdis-2016-209709 ID - Mease2017 ER - TY - JOUR AU - Tillett, W. AU - Jadon, D. AU - Shaddick, G. AU - Robinson, G. AU - Sengupta, R. AU - Korendowych, E. PY - 2014 DA - 2014// TI - Feasibility, reliability, and sensitivity to change of four radiographic scoring methods in patients with psoriatic arthritis JO - Arthritis Care Res. VL - 66 UR - https://doi.org/10.1002/acr.22104 DO - 10.1002/acr.22104 ID - Tillett2014 ER - TY - JOUR AU - Mease, P. J. AU - McInnes, I. B. AU - Kirkham, B. AU - Kavanaugh, A. AU - Rahman, P. AU - Heijde, D. PY - 2015 DA - 2015// TI - Secukinumab inhibition of interleukin-17a in patients with psoriatic arthritis JO - N Engl J Med. VL - 373 UR - https://doi.org/10.1056/NEJMoa1412679 DO - 10.1056/NEJMoa1412679 ID - Mease2015 ER - TY - JOUR AU - Eder, L. AU - Chandran, V. AU - Gladman, D. D. PY - 2011 DA - 2011// TI - Repair of radiographic joint damage following treatment with etanercept in psoriatic arthritis is demonstrable by 3 radiographic methods JO - J Rheumatol. VL - 38 UR - https://doi.org/10.3899/jrheum.100919 DO - 10.3899/jrheum.100919 ID - Eder2011 ER - TY - JOUR AU - Mease, P. J. AU - Gladman, D. D. AU - Samad, A. S. AU - Coates, L. C. AU - Liu, L. X. H. AU - Aras, G. A. PY - 2018 DA - 2018// TI - Design and rationale of the Study of Etanercept and Methotrexate in Combination or as Monotherapy in Subjects with Psoriatic Arthritis (SEAM-PsA) JO - RMD Open. VL - 4 UR - https://doi.org/10.1136/rmdopen-2017-000606 DO - 10.1136/rmdopen-2017-000606 ID - Mease2018 ER - TY - JOUR AU - Mease, P. J. AU - Landewe, R. B. M. AU - Rahman, P. AU - Tahir, H. AU - Singhai, A. AU - Boettcher, E. PY - 2019 DA - 2019// TI - Subcutaneous secukinumab 300 mg and 150 mg provides sustained inhibition of radiographic progression in psoriatic arthritis over 2 years: results from the phase 3 FUTURE-5 trial JO - Ann Rheum Dis. VL - 78 ID - Mease2019 ER - TY - JOUR AU - Landewé, R. AU - Heijde, D. PY - 2005 DA - 2005// TI - Radiographic progression in rheumatoid arthritis JO - Clin Exp Rheumatol. VL - 23 ID - Landewé2005 ER - TY - JOUR AU - Landewe, R. B. AU - Connell, C. A. AU - Bradley, J. D. AU - Wilkinson, B. AU - Gruben, D. AU - Strengholt, S. AU - Heijde, D. PY - 2016 DA - 2016// TI - Is radiographic progression in modern rheumatoid arthritis trials still a robust outcome? JO - Experience from tofacitinib clinical trials. Arthritis Res Ther. VL - 18 UR - https://doi.org/10.1186/s13075-016-1106-y DO - 10.1186/s13075-016-1106-y ID - Landewe2016 ER - TY - JOUR AU - Heijde, D. AU - Landewe, R. PY - 2018 DA - 2018// TI - Should radiographic progression still be used as outcome in RA? JO - Clin Immunol. VL - 186 UR - https://doi.org/10.1016/j.clim.2017.07.022 DO - 10.1016/j.clim.2017.07.022 ID - Heijde2018 ER - TY - STD TI - Cosentyx (secukinumab) [package insert]. East Hanover, NJ: Novartis Pharmaceuticals Corporation; June 2018. ID - ref41 ER - TY - JOUR AU - Gladman, D. D. AU - Mease, P. J. AU - Choy, E. H. AU - Ritchlin, C. T. AU - Perdok, R. J. AU - Sasso, E. H. PY - 2010 DA - 2010// TI - Risk factors for radiographic progression in psoriatic arthritis: subanalysis of the randomized controlled trial ADEPT JO - Arthritis Res Ther. VL - 12 UR - https://doi.org/10.1186/ar3049 DO - 10.1186/ar3049 ID - Gladman2010 ER - TY - JOUR AU - Heijde, D. AU - Gladman, D. D. AU - FitzGerald, O. AU - Kavanaugh, A. AU - Graham, D. AU - Wang, C. AU - Fallon, L. PY - 2019 DA - 2019// TI - Radiographic progression according to baseline c-reactive protein levels and other risk factors in psoriatic arthritis treated with tofacitinib or adalimumab JO - J Rheumatol. VL - 46 UR - https://doi.org/10.3899/jrheum.180971 DO - 10.3899/jrheum.180971 ID - Heijde2019 ER - TY - JOUR AU - Ibrahim, A. AU - Gladman, D. D. AU - Thavaneswaran, A. AU - Eder, L. AU - Helliwell, P. AU - Cook, R. J. AU - Chandran, V. PY - 2017 DA - 2017// TI - Sensitivity and specificity of radiographic scoring instruments for detecting change in axial psoriatic arthritis JO - Arthritis Care Res. VL - 69 UR - https://doi.org/10.1002/acr.23189 DO - 10.1002/acr.23189 ID - Ibrahim2017 ER - TY - JOUR AU - Østergaard, M. AU - Eder, L. AU - Christiansen, S. N. AU - Kaeley, G. S. PY - 2016 DA - 2016// TI - Imaging in the diagnosis and management of peripheral psoriatic arthritis-The clinical utility of magnetic resonance imaging and ultrasonography JO - Best Pract Res Clin Rheumatol. VL - 30 UR - https://doi.org/10.1016/j.berh.2016.08.012 DO - 10.1016/j.berh.2016.08.012 ID - Østergaard2016 ER - TY - JOUR AU - Ostergaard, M. AU - McQueen, F. AU - Wiell, C. AU - Bird, P. AU - Boyesen, P. AU - Ejbjerg, B. PY - 2009 DA - 2009// TI - The OMERACT psoriatic arthritis magnetic resonance imaging scoring system (PsAMRIS): definitions of key pathologies, suggested MRI sequences, and preliminary scoring system for PsA Hands JO - J Rheumatol. VL - 36 UR - https://doi.org/10.3899/jrheum.090352 DO - 10.3899/jrheum.090352 ID - Ostergaard2009 ER - TY - JOUR AU - Cimmino, M. A. AU - Barbieri, F. AU - Boesen, M. AU - Paparo, F. AU - Parodi, M. AU - Kubassova, O. PY - 2012 DA - 2012// TI - Dynamic contrast-enhanced magnetic resonance imaging of articular and extraarticular synovial structures of the hands in patients with psoriatic arthritis JO - J Rheumatol Suppl. VL - 89 UR - https://doi.org/10.3899/jrheum.120242 DO - 10.3899/jrheum.120242 ID - Cimmino2012 ER -